Delivery Order SPE2DB24D2109-SPE2DB25FHWPU

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $1,578. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 28, 2024. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract has a ceiling value of $5,260.00 and a period of performance ending on May 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,968.83, is for the procurement of the medication Mounjaro (7.5 mg/0.5 ml pen). The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the U.S. Defense Logistics Agency (DLA) Troop Support Medical with Mounjaro 10 mg/0.5 ml pens at a ceiling value of $2,967.76. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 2.5 mg/0.5 mL pens. The contract has a ceiling value of $23,188.94 and runs through July 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has a ceiling value of $3,063.57 and a performance period through March 25, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, is for the delivery of the drug Mounjaro (2.5 mg/0.5 ml pen). The $3,419.00 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to...
This is a delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 2.5 mg/0.5 ml pens. The award has a ceiling value of $19,707.28 and an ultimate completion date of May 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug Mounjaro, a 2.5 mg/0.5 ml pen with a 0.5 ml dosage form. The contract has a ceiling value of $5,596.40 and runs through March 21, 2025. The award was made on March 20, 2025, and the contract is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB25FHWPU
    Delivery Order

This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro in a 2.5 mg/0.5 mL pen. The contract has a ceiling value of $18,865.80 and runs through March 2025. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a total potential value of $999,999,999 and expires in November 2026. This IDC serves as a primary vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a prime contractor, AmerisourceBergen Drug Corp is responsible for the delivery of this medication to the DLA.

Generated 6/18/25, 11:02 AM